AMN Healthcare Services, Inc. (AMN)

AMN Healthcare tops second-quarter 2025 earnings and revenue forecasts, but margins and segment sales face continued pressure.

AMN Healthcare Services, Inc. (NYSE:AMN ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Brian M. Scott - CFO & COO Caroline Sullivan Grace - President, CEO & Director Randle G.

The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

AMN Healthcare Services (AMN) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.98 per share a year ago.

Quarterly revenue of $658 million and Adjusted EBITDA of $58.3 million; GAAP loss of ($3.02) /share and adjusted EPS of $0.30

The 2025 Review of Physician and Advanced Practitioner Recruiting Incentives reports starting salaries and incentives offered by hospitals & medical groups

AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

DALLAS, July 10, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2025 financial results and third quarter 2025 outlook on Thursday, August 7, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.

AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.

AMN Healthcare is undervalued, trading below $900 million market cap, with strong free cash flow and recent strategic moves to reduce net debt. The sale of Symplr and board expertise in M&A position AMN for further portfolio optimization and potential value-unlocking transactions. Despite recent goodwill impairments and cautious analyst outlooks, AMN's financial initiatives and management actions could attract renewed investor interest.

Strengthening symplr's commitment to helping providers optimize staffing, operations, and outcomes HOUSTON , July 2, 2025 /PRNewswire/ -- symplr® , a leading provider of enterprise healthcare operations software backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners LLC (together with its affiliates, "Charlesbank"), has acquired the Smart Square® scheduling software from AMN Healthcare (NYSE: AMN).

Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management

AMN Healthcare (AMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The consensus price target hints at a 29.3% upside potential for AMN Healthcare (AMN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.